MENU
+Compare
ARSUF
Stock ticker: OTC
AS OF
Sep 26 closing price
Price
$23.50
Change
-$0.16 (-0.68%)
Capitalization
1.7B

ARSUF Fagron SA Forecast, Technical & Fundamental Analysis

Fagron SA is a pharmaceutical compounding company operating in Belgium... Show more

ARSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARSUF with price predictions
Oct 07, 2025

ARSUF sees MACD Histogram crosses below signal line

ARSUF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 03, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 14 instances where the indicator turned negative. In of the 14 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on September 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ARSUF as a result. In of 17 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.940) is normal, around the industry mean (18.744). P/E Ratio (17.150) is within average values for comparable stocks, (73.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.989). Dividend Yield (0.017) settles around the average of (0.030) among similar stocks. P/S Ratio (1.593) is also within normal values, averaging (47.108).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARSUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARSUF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

View a ticker or compare two or three
ARSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

ARSUF paid dividends on May 19, 2021

Fagron SA ARSUF Stock Dividends
А dividend of $0.18 per share was paid with a record date of May 19, 2021, and an ex-dividend date of May 17, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Fascinatio Boulevard 350
Phone
+31 883311288
Employees
3567
Web
https://www.fagron.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLPSX61.76N/A
N/A
ProFunds Bull Svc
FSSAX27.15N/A
N/A
Franklin Small Cap Growth Adv
GTTTX36.12N/A
N/A
Goldman Sachs Small Cp Val Insghts Inv
RTDAX17.21N/A
N/A
Russell Inv Multifactor US Equity A
MLACX4.92-0.03
-0.61%
NYLI Winslow Large Cap Growth Class C

ARSUF and Stocks

Correlation & Price change

A.I.dvisor tells us that ARSUF and CRDL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARSUF and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
CRDL - ARSUF
22%
Poorly correlated
-1.85%
AVCNF - ARSUF
12%
Poorly correlated
+6.14%
BSPK - ARSUF
2%
Poorly correlated
+18.52%
BIOGY - ARSUF
2%
Poorly correlated
N/A
PRFX - ARSUF
2%
Poorly correlated
-2.16%
More

Groups containing ARSUF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
Pharmaceuticals: Generic
industry (222 stocks)
3%
Poorly correlated
+0.29%